IVF Hartmann Holding AG
SIX:VBSN

Watchlist Manager
IVF Hartmann Holding AG Logo
IVF Hartmann Holding AG
SIX:VBSN
Watchlist
Price: 145 CHF -0.68% Market Closed
Market Cap: 345.3m CHF
Have any thoughts about
IVF Hartmann Holding AG?
Write Note

Intrinsic Value

The intrinsic value of one VBSN stock under the Base Case scenario is 142.92 CHF. Compared to the current market price of 145 CHF, IVF Hartmann Holding AG is Overvalued by 1%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VBSN Intrinsic Value
142.92 CHF
Overvaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
IVF Hartmann Holding AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for VBSN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about VBSN?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about IVF Hartmann Holding AG

Provide an overview of the primary business activities
of IVF Hartmann Holding AG.

What unique competitive advantages
does IVF Hartmann Holding AG hold over its rivals?

What risks and challenges
does IVF Hartmann Holding AG face in the near future?

Has there been any significant insider trading activity
in IVF Hartmann Holding AG recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for IVF Hartmann Holding AG.

Provide P/S
for IVF Hartmann Holding AG.

Provide P/E
for IVF Hartmann Holding AG.

Provide P/OCF
for IVF Hartmann Holding AG.

Provide P/FCFE
for IVF Hartmann Holding AG.

Provide P/B
for IVF Hartmann Holding AG.

Provide EV/S
for IVF Hartmann Holding AG.

Provide EV/GP
for IVF Hartmann Holding AG.

Provide EV/EBITDA
for IVF Hartmann Holding AG.

Provide EV/EBIT
for IVF Hartmann Holding AG.

Provide EV/OCF
for IVF Hartmann Holding AG.

Provide EV/FCFF
for IVF Hartmann Holding AG.

Provide EV/IC
for IVF Hartmann Holding AG.

Compare the intrinsic valuations
of IVF Hartmann Holding AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of IVF Hartmann Holding AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of IVF Hartmann Holding AG compared to its peers.

Compare the P/E ratios
of IVF Hartmann Holding AG against its peers.

Discuss the investment returns and shareholder value creation
comparing IVF Hartmann Holding AG with its peers.

Analyze the financial leverage
of IVF Hartmann Holding AG compared to its main competitors.

Show all profitability ratios
for IVF Hartmann Holding AG.

Provide ROE
for IVF Hartmann Holding AG.

Provide ROA
for IVF Hartmann Holding AG.

Provide ROIC
for IVF Hartmann Holding AG.

Provide ROCE
for IVF Hartmann Holding AG.

Provide Gross Margin
for IVF Hartmann Holding AG.

Provide Operating Margin
for IVF Hartmann Holding AG.

Provide Net Margin
for IVF Hartmann Holding AG.

Provide FCF Margin
for IVF Hartmann Holding AG.

Show all solvency ratios
for IVF Hartmann Holding AG.

Provide D/E Ratio
for IVF Hartmann Holding AG.

Provide D/A Ratio
for IVF Hartmann Holding AG.

Provide Interest Coverage Ratio
for IVF Hartmann Holding AG.

Provide Altman Z-Score Ratio
for IVF Hartmann Holding AG.

Provide Quick Ratio
for IVF Hartmann Holding AG.

Provide Current Ratio
for IVF Hartmann Holding AG.

Provide Cash Ratio
for IVF Hartmann Holding AG.

What is the historical Revenue growth
over the last 5 years for IVF Hartmann Holding AG?

What is the historical Net Income growth
over the last 5 years for IVF Hartmann Holding AG?

What is the current Free Cash Flow
of IVF Hartmann Holding AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for IVF Hartmann Holding AG.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
IVF Hartmann Holding AG

Current Assets 135.8m
Cash & Short-Term Investments 72m
Receivables 43.5m
Other Current Assets 20.3m
Non-Current Assets 39m
Long-Term Investments 234k
PP&E 36.7m
Intangibles 2m
Current Liabilities 29.5m
Accounts Payable 5.8m
Accrued Liabilities 9.7m
Other Current Liabilities 14.1m
Non-Current Liabilities 4.1m
Long-Term Debt 821k
Other Non-Current Liabilities 3.3m
Efficiency

Earnings Waterfall
IVF Hartmann Holding AG

Revenue
152.9m CHF
Cost of Revenue
-68.5m CHF
Gross Profit
84.4m CHF
Operating Expenses
-64.9m CHF
Operating Income
19.5m CHF
Other Expenses
-1.9m CHF
Net Income
17.6m CHF

Free Cash Flow Analysis
IVF Hartmann Holding AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

VBSN Profitability Score
Profitability Due Diligence

IVF Hartmann Holding AG's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

54/100
Profitability
Score

IVF Hartmann Holding AG's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

VBSN Solvency Score
Solvency Due Diligence

IVF Hartmann Holding AG's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

IVF Hartmann Holding AG's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VBSN Price Targets Summary
IVF Hartmann Holding AG

There are no price targets for VBSN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for VBSN?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for VBSN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

VBSN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

IVF Hartmann Holding AG Logo
IVF Hartmann Holding AG

Country

Switzerland

Industry

Health Care

Market Cap

348m CHF

Dividend Yield

2.21%

Description

IVF HARTMANN Holding AG engages in the production and distribution of medical consumer products. The company is headquartered in Neuhausen Am Rheinfall, Schaffhausen and currently employs 340 full-time employees. The company went IPO on 2012-07-16. The firm's product range includes bandages, rheumatism plasters, baby products, feminine hygiene, cotton wool, first aid, diagnostics equipment, X-ray protection clothing, among others. The Company’s main clients usually are hospitals, doctors, surgery centers, care centers, pharmacies, drugstores, wholesalers and corporate medical centers. The firm also offers consulting services, on-site or in classrooms, related to the usage of its products. The firm's activities are divided into research and development, distribution logistics, production planning, purchase and four production segments: Coating; Medical Products; Elastic Bandages, and Hygiene Products. The company also operates subsidiaries located in Switzerland.

Contact

SCHAFFHAUSEN
NEUHAUSEN AM RHEINFALL
Victor-von-Bruns-Strasse 28

IPO

2012-07-16

Employees

340

Officers

Chief Executive Officer
Dr. Claus Martini
Chief Financial Officer
Dr. Hannes Leu
Chief Operations Officer
Mr. Bernd Deny

See Also

Discover More
What is the Intrinsic Value of one VBSN stock?

The intrinsic value of one VBSN stock under the Base Case scenario is 142.92 CHF.

Is VBSN stock undervalued or overvalued?

Compared to the current market price of 145 CHF, IVF Hartmann Holding AG is Overvalued by 1%.

Back to Top